Cite

1. Le HQ, Knudsen SJ. Exposure to a First World War blistering agent. Emerg Med J 2006;23:296-9.10.1136/emj.2005.032540Search in Google Scholar

2. Schmidt A, Bolck B, Jedig M, Steinritz D, Balszuweit F, Kehe K, Bloch W. Nitrogen mustard (Chlorambucil) has a negative influence on early vascular development. Toxicology 2009;263:32-40.10.1016/j.tox.2008.09.015Search in Google Scholar

3. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for sulfur mustards. Atlanta (GA): US Department of Health and Human Services, Public Health Service; 2007.Search in Google Scholar

4. Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 1993;9:259-67.10.1007/BF00755604Search in Google Scholar

5. Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 2006;80:662-70.10.1007/s00204-006-0089-xSearch in Google Scholar

6. Paromov V, Qui M, Yang H, Smith M, Stone WL. The influence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue. BMC Cell Biol 2008;9:33. doi:10.1186/1471-2121-9-3310.1186/1471-2121-9-33Search in Google Scholar

7. Ucar M, Korkmaz A, Reiter RJ, Yaren H, oter S, Kurt B, Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 2007;173:124-31.10.1016/j.toxlet.2007.07.005Search in Google Scholar

8. McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG, Smith mg, Ward PA. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 2006;26:126-31.10.1002/jat.1115Search in Google Scholar

9. Hardej D, Billack B. Ebselen protects brain, skin, lung, and blood cells from mechlorethamine toxicity. Toxicol Ind Health 2007;23:209-21.10.1177/0748233707083541Search in Google Scholar

10. Holl V, Coelho D, Silbernagel L, Keyser JF, Waltzinger C, Dufour P, Bischoff PL. Prevention of nitrogen mustardinduced apoptosis in normal and transformed lymphocytes by ebselen. Biochem Pharmacol 2000;60:1565-77.10.1016/S0006-2952(00)00480-9Search in Google Scholar

11. Khan S, Ramwani JJ, O’Brien PJ. Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation. Biochem Pharmacol 1992;43:1963-7.10.1016/0006-2952(92)90639-ZSearch in Google Scholar

12. Pino MA, Billack B. Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells. Cutan Ocul Toxicol 2008;27:161-72.10.1080/15569520802092070Search in Google Scholar

13. Mugesh G, du Mont W, Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem Rev 2001;101:2125-79.10.1021/cr000426wSearch in Google Scholar

14. Bhabak K, Mugesh G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc Chem Res 2010;43:1408-19.10.1021/ar100059gSearch in Google Scholar

15. Kanda N, Watanabe S. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. J Invest Dermatol 2002;119:1080-9.10.1046/j.1523-1747.2002.19510.xSearch in Google Scholar

16. Lazarova Z, Domloge-Hultsch N, Yancey KB. Epiligrin is decreased in papulonodular basal cell carcinoma tumor nest basement membranes and the extracellular matrix of transformed human epithelial cells. Exp Dermatol 1995;4:121-9.10.1111/j.1600-0625.1995.tb00235.xSearch in Google Scholar

17. Radkar V, Hardej D, Lau-Cam C, Billack B. Evaluation of resveratrol and piceatannol cytoxicity in macrophages, T cells, and skin cells. Arh Hig Rada Toksikol 2007;58:292-304.10.2478/v10004-007-0020-8Search in Google Scholar

18. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.10.1093/jnci/51.5.1417Search in Google Scholar

19. Wojtowicz H, Kloc K, Maliszewska I, Młochowski J, Pietka M, Piasecki E. Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties. Farmaco 2004;59:863-8.10.1016/j.farmac.2004.07.003Search in Google Scholar

20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.10.1016/0022-1759(83)90303-4Search in Google Scholar

21. Shah SJ, Sylvester PW. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 2005;230:235-41.10.1177/15353702052300040215792944Search in Google Scholar

22. Ghose AK, Viswanadhan VN, Wendoloski JJ. Prediction of hydrophobic (Lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem A 1998;102:3762-72.10.1021/jp980230oSearch in Google Scholar

23. Graham JS, Stevenson RS, Mitcheltree LW, Hamilton TA, Deckert RR, Lee RB, Schiavetta AM. Medical management of cutaneous sulfur mustard injuries. Toxicology 2009;263:47-58.10.1016/j.tox.2008.07.067Search in Google Scholar

24. Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 2006;31:1-5.10.1111/j.1365-2230.2005.01945.xSearch in Google Scholar

25. Bhat KR, Benton BJ, Rosenthal DS, Smulson ME, Ray R. Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur mustard-exposed normal human epidermal keratinocytes (NHEK). J Appl Toxicol 2000;20(Suppl 1): S13-7.10.1002/1099-1263(200012)20:1+<::AID-JAT695>3.0.CO;2-GSearch in Google Scholar

26. Kehe K, Balszuweit F, Steinritz D, Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 2009;263:12-9.10.1016/j.tox.2009.01.019Search in Google Scholar

27. Gordon MK, Desantis A, Deshmukh M, Lacey CJ, Hahn RA, Beloni J, Anumolu SS, Schlager JJ, Gallo MA, Gerecke DR, Heindel ND, Svoboda KK, Babin MC, Sinko PJ. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther 2010;26:407-19.10.1089/jop.2010.0099Search in Google Scholar

28. Jain AK, Tewari-Singh N, Gu M, Inturi S, White CW, Agarwal R. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol Lett 2011;205:293-301.10.1016/j.toxlet.2011.06.019Search in Google Scholar

29. Giocanti N, Hennequin C, Rouillard D, Defrance R, Favaudon V. Additive interaction of gefitinib (‘Iressa’, ZD1839) and ionising radiation in human tumour cells in vitro. Br J Cancer 2004;91:2026-33.10.1038/sj.bjc.6602242Search in Google Scholar

30. Reiss M, Brash DE, Munoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol Res 1992;4:349-57.Search in Google Scholar

31. Pereko T, Janncinova V, Drabikova K, Nosal R, Harmatha J. Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuro Endocrinol Lett 2008;29:802-5.Search in Google Scholar

32. Tripathi DN, Jena GB. Ebselen attenuates cyclophosphamideinduced oxidative stress and DNA damage in mice. Free Radic Res 2008;42:966-77.10.1080/10715760802566558Search in Google Scholar

33. Wagner G, Schuch G, Akerboom TP, Sies H. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem Pharmacol 1994;48:1137-44.10.1016/0006-2952(94)90150-3Search in Google Scholar

34. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci 1985;311:617-31.10.1098/rstb.1985.0168Search in Google Scholar

35. Nozawa R, Arai M, Kuruto R, Motohashi T, Masayasu H. Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. J Pharm Pharmacol 1996;8:64-7.Search in Google Scholar

36. Masumoto H, Sies H. The reaction of ebselen with peroxynitrite. Chem Res Toxicol 1996;9:262-7.10.1021/tx950115uSearch in Google Scholar

37. Bien M, Blaszczyk B, Kalinowska K, mLochowski J, Inglot AD. Anitfungal activity of 2-(4-chlorophenyl)-1.2 benzisoselenazol-3(2H)-one, the analog of Ebselen. Arch Immunol Ther Exp (Warsz)1999;47:185-93.Search in Google Scholar

38. Wojtowicz H, Chojnacka M, mLochowski J, Palus J, Syper L, Hudcova D. Functionalized alkyl and aryl diselenides as antimicrobial and antiviral agents: synthesis and properties. Il Farmaco 2003;58:1235-42.10.1016/j.farmac.2003.08.003Search in Google Scholar

39. Pietka-Ottlik M, Wojtowicz-Mlochowska H, Kolodziejczyk K, Piasecki E, mLochowski J. New organoselenium compounds active against pathogenic bacteria, fungi and viruses, Chem Pharm Bull (Tokyo) 2008;56:1423-7.Search in Google Scholar

40. Olm E, Jonsson-Videsater K, Ribera-Cortada I, Fernandes AP, Eriksson LC, Lehmann S, Rundlof AK, Paul C, Bjornstedt M. Selenite is a potent cytotoxic agent for human primary AML cells. Cancer Lett 2009;282:116-23.10.1016/j.canlet.2009.03.010Search in Google Scholar

41. Funk D, Schrenk HH, Frei E. Serum albumin leads to falsepositive results in the XTT and the MTT assay. Biotechniques 2007;43:178-86.10.2144/000112528Search in Google Scholar

42. Schroterova L, Kralova V, Voracova A, Haskova P, Rudolf E, Cervinka M. Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays. Toxicol In Vitro 2009;23:1406-11.10.1016/j.tiv.2009.07.013Search in Google Scholar

43. Kim SJ, Park C, Han AL, Youn MJ, Lee JH, Kim Y, Kim ES, Kim HJ, Kim JK, Lee HK, Chung SY, So H, Park R. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res 2009;251:70-82.10.1016/j.heares.2009.03.003Search in Google Scholar

44. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 1987;44:255-76.10.1016/0009-3084(87)90053-3Search in Google Scholar

ISSN:
0004-1254
Languages:
English, Slovenian
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, other